Show simple item record

AuthorChemaitelly, Hiam
AuthorCoyle, Peter
AuthorKacem, Mohamed Ali Ben
AuthorAyoub, Houssein H.
AuthorTang, Patrick
AuthorHasan, Mohammad R.
AuthorYassine, Hadi M.
AuthorAl Thani, Asmaa A.
AuthorAl-Kanaani, Zaina
AuthorAl-Kuwari, Einas
AuthorJeremijenko, Andrew
AuthorKaleeckal, Anvar H.
AuthorLatif, Ali N.
AuthorShaik, Riyazuddin M.
AuthorAbdul-Rahim, Hanan F.
AuthorNasrallah, Gheyath K.
AuthorAl-Kuwari, Mohamed Ghaith
AuthorButt, Adeel A.
AuthorAl-Romaihi, Hamad E.
AuthorAl-Thani, Mohamed H.
AuthorAl-Khal, Abdullatif
AuthorBertollini, Roberto
AuthorAbu-Raddad, Laith J.
Available date2024-09-09T10:12:29Z
Publication Date2024-05-01
Publication NameJournal of Travel Medicine
Identifierhttp://dx.doi.org/10.1093/jtm/taae053
CitationHiam Chemaitelly, Peter Coyle, Mohamed Ali Ben Kacem, Houssein H Ayoub, Patrick Tang, Mohammad R Hasan, Hadi M Yassine, Asmaa A Al Thani, Zaina Al-Kanaani, Einas Al-Kuwari, Andrew Jeremijenko, Anvar H Kaleeckal, Ali N Latif, Riyazuddin M Shaik, Hanan F Abdul-Rahim, Gheyath K Nasrallah, Mohamed Ghaith Al-Kuwari, Adeel A Butt, Hamad E Al-Romaihi, Mohamed H Al-Thani, Abdullatif Al-Khal, Roberto Bertollini, Laith J Abu-Raddad, Protection of natural infection against reinfection with SARS-CoV-2 JN.1 variant, Journal of Travel Medicine, Volume 31, Issue 4, May 2024, taae053, https://doi.org/10.1093/jtm/taae053
ISSN11951982
URIhttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85194584159&origin=inward
URIhttp://hdl.handle.net/10576/58677
AbstractEvidence at the level of neutralizing antibodies suggests that the SARS-CoV-2 JN.1 variant demonstrates increased immune evasion compared to its parent lineage BA.2.86 and to recently circulating variants, such as XBB.1.5 and EG.5.1.1 JN.1 has also exhibited a growth advantage over other variants and triggered large SARS-CoV-2 waves in various countries,2 prompting the World Health Organization to classify it as a variant of interest on 19 December 2023.2 We estimated the effectiveness of natural infection in preventing reinfection with JN.1 during a large JN.1 wave in Qatar using the test-negative case-control study design.3,4
SponsorThe authors are grateful for support from the Biomedical Research Program and the Biostatistics, Epidemiology, and Biomathematics Research Core at Weill Cornell Medicine–Qatar, the Qatar Ministry of Public Health, Hamad Medical Corporation and Sidra Medicine. The authors are also grateful for the Qatar Genome Programme and Qatar University Biomedical Research Center for institutional support for the reagents needed for the viral genome sequencing.
Languageen
PublisherOxford University Press
Subjectcase-control
COVID-19
epidemiology
immunity
reinfection
test-negative
TitleProtection of natural infection against reinfection with SARS-CoV-2 JN.1 variant
TypeArticle
Issue Number4
Volume Number31
ESSN1708-8305
dc.accessType Open Access


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record